159 related articles for article (PubMed ID: 12682159)
1. Tandem tetramer-based microsatellite fingerprinting for typing of Proteus mirabilis strains.
Cieślikowski T; Gradecka D; Mielczarek M; Kaca W
J Clin Microbiol; 2003 Apr; 41(4):1673-80. PubMed ID: 12682159
[TBL] [Abstract][Full Text] [Related]
2. Arbitrarily primed polymerase chain reaction provides rapid differentiation of Proteus mirabilis isolates from a pediatric hospital.
Bingen E; Boissinot C; Desjardins P; Cave H; Brahimi N; Lambert-Zechovsky N; Denamur E; Blot P; Elion J
J Clin Microbiol; 1993 May; 31(5):1055-9. PubMed ID: 8099079
[TBL] [Abstract][Full Text] [Related]
3. Comparison of PCR-based molecular markers for the characterization of Proteus mirabilis clinical isolates.
Michelim L; Muller G; Zacaria J; Delamare AP; Costa SO; Echeverrigaray S
Braz J Infect Dis; 2008 Oct; 12(5):423-9. PubMed ID: 19219283
[TBL] [Abstract][Full Text] [Related]
4. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
[TBL] [Abstract][Full Text] [Related]
5. A novel functional class 2 integron in clinical Proteus mirabilis isolates.
Wei Q; Hu Q; Li S; Lu H; Chen G; Shen B; Zhang P; Zhou Y
J Antimicrob Chemother; 2014 Apr; 69(4):973-6. PubMed ID: 24235093
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Proteus mirabilis by bacteriophage typing and the Dienes reaction.
Hickman FW; Farmer JJ
J Clin Microbiol; 1976 Mar; 3(3):350-8. PubMed ID: 773962
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the discriminatory powers of the Dienes test and ribotyping as typing methods for Proteus mirabilis.
Pfaller MA; Mujeeb I; Hollis RJ; Jones RN; Doern GV
J Clin Microbiol; 2000 Mar; 38(3):1077-80. PubMed ID: 10699000
[TBL] [Abstract][Full Text] [Related]
8. Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13.
Schultz E; Haenni M; Mereghetti L; Siebor E; Neuwirth C; Madec JY; Cloeckaert A; Doublet B
J Antimicrob Chemother; 2015 Sep; 70(9):2543-6. PubMed ID: 26066582
[TBL] [Abstract][Full Text] [Related]
9. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
[TBL] [Abstract][Full Text] [Related]
10. Comparison of phenotypic and virulence genes characteristics in human and chicken isolates of Proteus mirabilis.
Barbour EK; Hajj ZG; Hamadeh S; Shaib HA; Farran MT; Araj G; Faroon O; Barbour KE; Jirjis F; Azhar E; Kumosani T; Harakeh S
Pathog Glob Health; 2012 Oct; 106(6):352-7. PubMed ID: 23182140
[TBL] [Abstract][Full Text] [Related]
11. Typing of Proteus mirabilis from clinical sources by computerized analysis of electrophoretic protein patterns.
Holmes B; Costas M; Wood AC
J Appl Bacteriol; 1991 Nov; 71(5):467-76. PubMed ID: 1761440
[TBL] [Abstract][Full Text] [Related]
12. Clonal relatedness of Proteus mirabilis strains causing urinary tract infections in companion animals and humans.
Marques C; Belas A; Aboim C; Trigueiro G; Cavaco-Silva P; Gama LT; Pomba C
Vet Microbiol; 2019 Jan; 228():77-82. PubMed ID: 30593384
[TBL] [Abstract][Full Text] [Related]
13. Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.
Drzewiecka D; Arbatsky NP; Shashkov AS; Staczek P; Knirel YA; Sidorczyk Z
FEMS Immunol Med Microbiol; 2008 Nov; 54(2):185-94. PubMed ID: 18665848
[TBL] [Abstract][Full Text] [Related]
14. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
Szymaniak L; Aleksandrowicz I; Giedrys-Kalemba S
Med Dosw Mikrobiol; 1999; 51(3-4):323-30. PubMed ID: 10803261
[TBL] [Abstract][Full Text] [Related]
15. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
Yong D; Lim YS; Roh KH; Choi YS; Park DY; Yum JH; Kim JM; Lee K; Chong Y
Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
[TBL] [Abstract][Full Text] [Related]
16. Typing of proteus from patients with bacteriuria.
Clarke SC; McIntyre M
J R Soc Health; 1996 Feb; 116(1):27-9. PubMed ID: 8683538
[TBL] [Abstract][Full Text] [Related]
17. Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, France.
Siebor E; Neuwirth C
J Antimicrob Chemother; 2013 Aug; 68(8):1750-6. PubMed ID: 23580563
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of Proteus mirabilis and Proteus vulgaris strains by means of proticine typing: a longitudinal epidemiological study.
Sekaninová G; Kolárová M
Cent Eur J Public Health; 1996 May; 4(2):98-101. PubMed ID: 8996720
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Proteus mirabilis isolates in Taiwan.
Huang CW; Chien JH; Peng RY; Tsai DJ; Li MH; Lee HM; Lin CF; Lee MC; Liao CT
Int J Antimicrob Agents; 2015 Jan; 45(1):84-5. PubMed ID: 25446905
[No Abstract] [Full Text] [Related]
20. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
